|
[1]
|
朱源荣, 陆建华, 王金兵等. 肝癌高发区不同人群乙肝及丙肝病毒标志物阳性率的变化[J]. 中国肿瘤, 2011, 20(6): 409- 412.
|
|
[2]
|
张涛, 单利. 高尔基体蛋白73与恶性肿瘤关系的研究进展[J]. 医学综述, 2010, 16(22): 3421-3423.
|
|
[3]
|
高松, 崔书, 巴明臣. GP73在肝癌诊断中的研究现状及前景[J]. 中华肝胆外科杂志, 2010, 16(12): 961-963.
|
|
[4]
|
王维林, 白鑫, 屠红. 肝癌血清标志物研究的新进展[J]. 肿瘤, 2009, 29(4): 389-393.
|
|
[5]
|
肖莉. GP73和肝脏疾病关系的研究进展[J]. 医学信息, 2010 23(11): 331.
|
|
[6]
|
谭龙益. Ⅱ型高尔基体膜蛋白与人类肝脏疾病的关系[J]. 中华肝脏病杂志, 2007, 15(2): 958-959.
|
|
[7]
|
李淑群, 陈谦. GP73与肝脏疾病关系的研究进展[J]. 世界华人消化杂志, 2010, 18(20): 2117-2120.
|
|
[8]
|
杨盛力, 潘晓莉. GP73的研究进展[J]. 肝胆外科杂志, 2011, 19(1): 70-72．
|
|
[9]
|
R. D. Kladney, G. A. Bulla, L. Guo, et al. GP73, a novel Golgi- localized protein upregulated by viral infection. Gene, 2000, 249 (1-2): 53-65.
|
|
[10]
|
S. Puri, C. Bachert, C. J. Fimmel, et al. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal PH disruption. Traffic, 2002, 3(9): 641-653.
|
|
[11]
|
R. Natarajan, A. D. Linstedt. A Cyclin Cis-Golgi Protein ma- diates endosme-to-Golgi traffic. Molecular Biology Cell, 2004, 15 (11): 4798-4806.
|
|
[12]
|
C. Rabouile, E. Jokitalo. Golgi apparatus partition in during cell division. Molecular Memberance Biology, 2003, 20(2): 117-127.
|
|
[13]
|
S. Mukherjee, R. Chiu, S. M. Leung, et al. Fragmentation of the Golgi apparatus an early apoptotic event in dependent of the Cytoskeleton. Traffic, 2007, 8(4): 369-378.
|
|
[14]
|
C. Bachert, C. Fimmel and A. D. Linsted. Endosomal trafficking and Proprotein Convertase eleavage of Cis golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic, 2007, 8: 1415-1423.
|
|
[15]
|
J. S. Hu, D. W. Wu, S. Liang, et al. GP73, a resident Golgi glycoprotein, is Sensibility and specificity for hepatocellular car- cinoma of diagnosis in a hepatitis B-endemic Asian population. Medical Oncology, 2009, 27(2): 339-345.
|
|
[16]
|
S. Varambally, B. Laxman, R. Mehra, et al. Golgi protein in GOLMI is a tissue and urine biomasker of prostate cancer. Neo- plasia, 2008, 10(11): 1285-1294.
|
|
[17]
|
L. M. Wright, S. Yong, M. M. Picken, et al. Decreased survival and hepato-renal pathology in mice C-terminally truncated GP73 (GOLPH2). International Journal of Clinical Experimental Pa- thology, 2009, 2(1): 34-47.
|
|
[18]
|
A. Maitra, P. J. Thuluvath. GP73 and liver disease: A (golgi) complex enigma. American Journal of Gastroenterology, 2004, 99: 1096-1098.
|
|
[19]
|
F. R. Fritzsche, M. O. Riener, M. Dietel, et al. GOLPH2 expre- ssion in renal cell cancer. BMC Urology, 2008, 8: 15.
|
|
[20]
|
D. Song, R. Chaerkdy, A. C. Tan, et al. Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor IP1-504 in Pancreatic Cancer. Molecular Cancer Therapeutics, 2008, 7(10): 3275-3284.
|
|
[21]
|
F. R. Fritzsche, G. Kristiansen, M. O. Riener, et al. GOLPH2 expression may serve as diagnositic marker in seminomas. BMC Urology, 2010, 10: 4.
|
|
[22]
|
M. O. Riener, F. Stenner, H. Liewen, et al. Golgi phosphoprotein 2(GOLPH2) experssion in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology, 2009, 49(5): 1602-1609.
|
|
[23]
|
F. Zhang, et al. Upregulated Golgi phosphoprotein 2(GOLPH2) experssion in lung a denocarcinoma tissue. Clinical Biochemi- stry, 2010, 43(12): 983-991.
|
|
[24]
|
R. D. Kladney, X. Gui, G. A. Bulla, et al. Expression of GP73, a resident golgi membrane protein, in viral and nonviral liver di- sease. Hepatology, 2002, 35(6): 1431-1440.
|
|
[25]
|
R. D. Kladney, A. E. Tollefson, W. S. Wold, et al. Upregulation of the golgi protein GP73 by adenovirus infection requires the EIA CtBp interaction domain. Virology, 2002, 301: 236-246.
|
|
[26]
|
R. Iftikhar, R. D. Kladney, N. Havlioglu, et al. Disease-and cell- specific expresesion of GP73 in human liver disease. American Journal of Gastroenterology, 2004, 99(6): 1087-1095.
|
|
[27]
|
T. M. Block, M. A. Comanale, M. Lowman, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. National Proceeding Academy Sciences USA, 2005, 102(3): 779-784.
|
|
[28]
|
J. A. Marrero, P. R. Romano, O. Nikolaeva, et al. GP73, a resident golgi glycoprotein is a novel serum marker for heap- tocellular carcinoma. Journal of Hepatology, 2005, 43(6): 1007- 1012.
|
|
[29]
|
E. E. Schwegler, L. Cazares, L. F. Steel, et al. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology, 2005, 41: 634-642.
|
|
[30]
|
S. Srivastava. Cancer biomarker discovery and development in gastrointestinal cancers: Early detection research network—A co- llaborative approach. Gastrointest Cancer Research, 2007, 1 (Suppl. 2): S60-3.
|
|
[31]
|
C. Willyard. Researchers look for “sweet” method to diagnosis Cancer. Nature Medicine, 2007, 13(11): 1267-1269.
|
|
[32]
|
S. Benowitz. Liver cancer biomarkers struggling to succeed. Journal of Nationall Cancer Institute, 2007, 99(8): 590-591.
|
|
[33]
|
W. Cassandra. Rosearchers look for “sweet” method to diagnose Cancer. Nature Medicine, 2007, 13: 1267.
|
|
[34]
|
毛一雷, 杨华瑜, 徐海峰等. 新的肝癌血清标记物GP73在肝癌诊断中的初步研究[J]. 中华医学杂志, 2008, 88(14): 948- 951.
|
|
[35]
|
徐海峰, 杨华瑜, 张宏冰等. 改变肝癌早期诊断和治疗现状的新肝癌血清标志物[J]. 基础医学与临床, 2008, 28(1): 104-108.
|
|
[36]
|
李利军, 李新丰, 王高雄. GP73联合AFP、VEGF 检测对原发性肝癌的诊断价值[J]. 世界华人消化杂志, 2009, 17(29): 3056-3060.
|
|
[37]
|
Y. Mao, H. Yang, H. Xu, et al. Golgi protein 73(GOLPH2) is a valuable serum marker for hepatocellula carcinoma. Gut, 2010, 59(12): 1687-1693.
|
|
[38]
|
付超, 齐军, 李学禅等. 高尔基体蛋白(GP73)检测在肝细胞癌中的应用价值[J]. 中国肿瘤, 2010, 19(8): 553-556.
|
|
[39]
|
赵秀英, 李英, 丁惠国等. 血清高尔基体糖蛋白73在肝细胞癌诊断中的作用[J]. 中华肿瘤杂志, 2010, 32(12): 943-946.
|
|
[40]
|
张祖平, 张德忠, 吴耀震. 血清GP73联合AFP对PHC的早期诊断价值探讨[J]. 放射免疫学杂志, 2010 23(2): 205-206.
|
|
[41]
|
张亚松, 石玉玲 张喜欽. GP73在肝癌早期诊断中的应用价值[J]. 医学临床研究, 2011, 28(4): 651-653.
|
|
[42]
|
梁冠林, 廖志学, 冉顺等. 血清GP73在肝脏肿瘤中的表达及意义[J]. 中华普通外科杂志, 2010, 25(4): 339-340.
|
|
[43]
|
李淑群, 陈谦, 喻亚群等. 肝细胞肝癌组织中GP73的表达变化[J]. 山东医药, 2011, 51(2): 60-61.
|
|
[44]
|
刘树业, 杜智, 邵新华等. 高尔基体蛋白73在肝癌诊断中的意义[J]. 广东医学, 2010, 31(3): 309-311.
|
|
[45]
|
石玉玲, 曾兰兰, 李林海等. 高尔基体蛋白73及其基因检测对原发性肝癌诊断的价值[J]. 中华检验医学杂志, 2010, 33(6): 507-512.
|
|
[46]
|
朱国民, 周晓庆, 林长青等. 新肝癌标志物高尔基体蛋白GP73在肝癌血清诊断中的应用[J]. 中华医院感染学杂志, 2010, 20(15): 2350-2352．
|
|
[47]
|
陈文莉, 彭涛, 陈小苹等. 血清GP73检测在肝脏疾病诊断中的临床意义[J]. 中华检验医学杂志, 2010, 33(4): 333-336.
|
|
[48]
|
谭龙益, 陈洁, 王皓. 血清Ⅱ型高尔基体膜蛋白与人类肝细胞癌的关系[J]. 中华肝脏病杂志, 2009, 17: 288-291.
|
|
[49]
|
M. S. Pepe, R. Etzioni, Z. Feng, et al. Phases of biomark de- velopment for early detection of cancer. Journal of Nationall Cancer Institute, 2001, 93(14): 1054-1061.
|
|
[50]
|
R. R. Darke, E. E. Schwegler, G. Malik, et al. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Molecular Cell Proteomics, 2006, 5(10): 1957-1967.
|